FDA — authorised 20 September 2021
- Application: BLA761208
- Marketing authorisation holder: SEAGEN
- Local brand name: TIVDAK
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Tivdak in United States
FDA authorised Tivdak on 20 September 2021
Marketing authorisation
Tivdak in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Tivdak approved in United States?
Yes. FDA authorised it on 20 September 2021.
Who is the marketing authorisation holder for Tivdak in United States?
SEAGEN holds the US marketing authorisation.